ThursdayDec 09, 2021 1:54 pm

Flora Growth Corp. (NASDAQ: FLGC) Launches European and Mexican Exports of CBD Skincare Brands

Colombian cannabis cultivator and international wellness product builder Flora Growth Corp. is building a global pipeline for its wide array of branded CBD and medicinal cannabis products The company recently announced that it has begun fulfilling the first orders for its Mind Naturals and Awe CBD skincare brands with exports to Spain and Mexico outlets this month Flora Growth cultivates cannabis at its 100-hectare (247-acre) property in central Colombia Flora also has a GMP certified 16,000-square-foot manufacturing facility in Bogota that produces nearly 200 products for the CBD derivatives and medical cannabis markets Cannabis cultivator and worldwide cannabidiol (“CBD”) brand…

Continue Reading

ThursdayDec 09, 2021 1:34 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Proceed with its Phase 2a Fibromyalgia Study Following FDA Confirmation

Tryp just announced FDA confirmation for its IND application filed in November 2021 The confirmation allows the company to proceed with its Phase 2a study on the effectiveness of psilocybin-assisted therapy among patients with fibromyalgia This clinical study will be one of the first to evaluate synthetic psilocybin for fibromyalgia in a Phase 2 study It is set to commence in 2022 and will involve 20 fibromyalgia patients Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) just announced that it would be proceeding with its upcoming Phase 2a fibromyalgia study, following a confirmation from the U.S. Food and Drug Administration (“FDA”) (https://ibn.fm/C20cT).…

Continue Reading

ThursdayDec 09, 2021 1:24 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) to Fund, Support First-Ever Psychedelic Treatment Clinic at Manhattan Hospital

Company receives grant to fund clinic for marginalized, underserved NYC communities New clinic will offer psychedelic treatment with no out-of-pocket cost for individuals unable to afford the service Program’s clinicians will receive specialized training Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is marking key milestones in its mission to revolutionize mental healthcare. The company recently received a grant for the first-ever psychedelic treatment clinic at Lenox Hill Hospital (https://ibn.fm/zyerA). Part of Northwell Health, the largest healthcare system in New York State, Lenox Hill Hospital serves marginalized and underserved communities on the Upper East…

Continue Reading

ThursdayDec 09, 2021 12:56 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Milestones Highlight HealthTab’s Endless Diagnostic Possibilities

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has, since the company’s inception, been driven by the development of a network of point-of-care (“POC”) analyzers that run on its HealthTab(TM) software in community pharmacies, workplaces and rural areas. Earlier this year, the company signed a deal with Abbott to expand the distribution of its Affinion 2 analyzers in pharmacies. Shortly thereafter, Avricore also entered an agreement with Shoppers Drug Mart to stock HealthTab for diabetes screening in 11 different locations. “The company has recognized an opportunity and capitalizes on established consumer trends, technology advancements, health policy and industry changes to solve a…

Continue Reading

ThursdayDec 09, 2021 12:16 pm

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces January 2022 Conference Participation Schedule

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced details regarding Matt Stang, co-founder and CEO of Delic, and his participation at upcoming January events. According to the update, he will present on the company’s expansion strategy and industry outlook heading into the new year and offer one-on-one meetings with investors at the HC Wainwright Bioconnect Conference. The virtual event is slated to take place Jan. 10-13, 2022, and feature numerous presenting companies, fireside discussions and meetings with H.C. Wainwright investment banking and research teams. In addition, Stang will…

Continue Reading

ThursdayDec 09, 2021 11:38 am

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Reports Record Revenue for Black Friday, Cyber Monday

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has released its revenue numbers for the 2021 Black Friday and Cyber Monday events; the company reported record-breaking numbers, with total revenue of C$153,000 and cost of goods for the same period reaching C$82,000. The promotions held during those two key events resulted in an “astonishing” 63% revenue increase of C$60,000 compared to the two events last year. “Our e-commerce sales success during Black Friday and Cyber Monday is extremely encouraging,” said PlantX founder Sean Dollinger in the press release. “We are determined to make the most of this momentum, build on our expansion efforts…

Continue Reading

ThursdayDec 09, 2021 10:48 am

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Issues Corporate Update on Tremendous Year of Growth, Eyes Game-Changing 2022

ISW Holdings (OTC: ISWH) (transitioning to “BlockQuarry,” pending name change), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining, today provided an update for current and prospective shareholders. Among the highlights, the company reported that its revenue run rate from its own cryptocurrency mining operations has begun to exceed internal and publicly stated expectations. In addition, phase one of the company’s Southeastern U.S. project to pair 56,000 mining rigs with 200 megawatts of power will soon go live, which will activate 20 MW of power deployed to self-contained cryptocurrency mining pods. Following full deployment and activation of all 200…

Continue Reading

ThursdayDec 09, 2021 9:26 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Subsidiary Brings New Offerings to Dry Herb Market

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, through its wholly owned subsidiary Vessel Brand, has entered the dry herb market. Vessel Brand is expanding into the market with a line of exclusive products, including an all-in-one dry herb smoking kit with an inverted lighter, a premium grinder, an artful ashtray and the company’s own take on the one-hitter with a spiralized interior. A flagship product in the new line of offerings is the Helix, a patent-pending, pure brass device designed to offer the cleanest inhalation possible. Another item grabbing attention is…

Continue Reading

WednesdayDec 08, 2021 3:48 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Secures Medical Device Certification for IoT-Powered Dry Herb Inhaler, Software

RYAH Group (CSE: RYAH) today announced that its subsidiary, RYAH Medtech Inc., has received ISO 13485:2016/MDSAP and EN ISO 13485:2016 certification for its proprietary Internet of Things (“IoT”)-powered dry herb inhaler (the “RYAH Smart Inhaler”) and software application associated with the device. According to the update, the certification is a regulatory requirement and an international standard that outlines the requirements for a quality management system specific to the medical devices industry. “This is a monumental achievement for RYAH Group Inc. and its subsidiary, RYAH Medtech Inc., as we continue to reimagine plant-based medicine delivery solutions for doctors, clinics and their…

Continue Reading

WednesdayDec 08, 2021 2:55 pm

QualityStocksNewsBreaks – Sharing Services Global Corporation (SHRG) Subsidiary Poised as Recognized Leader in Natural Nootropics

Sharing Services Global’s (OTCQB: SHRG) subsidiary the Happy Co., a direct-sales opportunity that offers functional beverages, capsules, patches and creams featuring nootropics, could witness significant benefit from the projected growth in the global nootropics market. A recent report projects that this space, which reached $2.42 billion in 2020, will top $6.29 billion by 2028, growing at a CAGR of 12.71% during the forecast period (https://ibn.fm/liOgS). The report attributes the growth to the rise in demand for cognitive enhancers or smart drugs among the global population to enhance memory and stay focused. “One of the fastest-growing companies in the social-marketing and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered